Owners and referring veterinarians mostly find enrolling studies in two places. One is the AVMA Veterinary Clinical Trials Registry, a free, searchable listing of veterinary studies in the US and Canada. The other is the clinical trials pages of university veterinary hospitals, which name each study, who qualifies and whom to call. To list your own study, get it approved first. Then write a short, plain description that matches the consent form, send it to the registry, put it on your own trials page and give referring vets one contact. Listing is voluntary. If the product is unapproved, nothing in the listing may say it is safe or effective.
Where owners and referring vets look
- The AVMA Veterinary Clinical Trials Registry, at veterinaryclinicaltrials.org. Washington State University's library describes it as a "free searchable database to connect animal owners and veterinarians with clinical studies in the U.S. and Canada." Tufts' veterinary library says users can search for studies on a condition, or offer health data or a sample from a healthy animal. The registry's own pages did not open for us today, so read its instructions for study personnel before you submit.
- University hospital trial pages. Virginia Tech's Veterinary Clinical Research Office keeps a Current Studies page. Each listing gives inclusion and exclusion criteria, study requirements, possible risks and side effects, the time and travel involved, and a contact. The page says "All referrals must be made by a veterinarian," and that studies are approved by a committee of the college's hospital directors and, where it applies, the university's IACUC. The University of Missouri lists current trials by service, gives one email address and tells owners to ask their veterinarian. Cornell runs a mailing list that tells referring vets about new trials and sends patients back to their own vet when a study ends.
- The owner's own veterinarian. Several of these pages send owners to their vet first, so the referring vet is the reader your listing has to convince.
How to list a study, step by step
- Settle the design: observational, a marketed product used on its label, or an unapproved product. It decides which rules the listing must respect.
- Get the study approved before you advertise it, and ask your review committee whether it wants to see the listing text. VICH GL9, published by FDA as Guidance #85, counts "information to be provided to the owners of animals" among the supplements to the protocol (section 6.3.20.3). The listing belongs in the protocol file with the consent form.
- Write the listing from the consent form, not from the sponsor's marketing. Each statement in the listing should also be in the consent form.
- Send it to the registry, publish it on your trials page and tell referring vets directly. Give one contact and say how a referral works.
- Keep it current. Date each version, change it when the protocol or consent changes, and take it down when enrollment closes.
What the rules say about a listing
- 21 CFR 511.1 is the rule for investigational new animal drugs. It asks for a notice to FDA before shipment, investigator records and sponsor monitoring. It does not ask for a public listing. It does limit what a sponsor may say. Under 511.1(b)(8)(iv) the sponsor "shall not represent that the new animal drug is safe or effective for the purposes for which it is under investigation." Under (b)(8)(v) the sponsor may not commercially distribute or test-market the drug before approval.
- VICH GL9 (FDA Guidance #85) section 3.2.13 asks the investigator to obtain informed consent from each owner before the animal takes part. The owner should first receive the relevant information from the investigator. A listing starts that conversation and does not replace it. Section 2.6 says studies "not intended to be used for regulatory support" are outside GL9's scope.
- FDA Guidance #282 is still a draft (September 2023). It covers consent forms for studies in client-owned dogs, cats and horses, and its advice carries over to a listing. Section V.B says to avoid statements that could be false or misleading, that suggest FDA endorses the study, or that raise "overly optimistic expectations." Section VI.A.2 asks for the chance of being in the control group. Section VI.B.7 treats payment to owners as compensation for expenses, not a benefit, and says it should not depend on finishing the study. Section II recommends that owners get the consent form at least 12 to 24 hours before enrollment, so do not promise a same-day start.
How the design changes the listing
- Observational study, nothing given. 511.1 does not apply, and if the data are not meant for a regulator, GL9 does not either. The listing describes what the owner does, how many visits there are, what is measured and who will see the records. Your institution's review still applies if your institution requires it.
- Marketed product used on its label. Nothing investigational is shipped, so 511.1(b)(8)(iv) does not attach. Describe the question the study asks, not the product's merits, and say plainly if one group gets a placebo or a comparison product.
- Unapproved product. 511.1 applies in full. Say that the product is investigational and is not approved for this use, which is what Guidance #282 sections VI.A.1 and VI.H ask of the consent form. Leave out "safe," "effective," "proven" and "breakthrough," and anything that sounds like the product is available outside the study.
What a listing should contain
| Item | What to write | Where it comes from |
|---|---|---|
| Title and identifier | A plain title, the protocol number and the version date | GL9 6.3.1, 6.3.2 |
| Who can join | Species, condition, main inclusion and exclusion criteria | Virginia Tech listings; GL9 6.3.10 |
| What taking part involves | Visits, procedures, owner diary, length, travel | Virginia Tech listings; Guidance #282 VI.A.4, VI.D |
| Product status | Investigational and not approved for this use, where that is true | Guidance #282 VI.A.1 |
| Groups | The groups, and the chance of placebo or control | Guidance #282 VI.A.2 |
| Risks | Known side effects and procedure risks, in plain words | Virginia Tech listings; Guidance #282 VI.E |
| Costs and compensation | What is covered, what is not, any payment, not called a benefit | Guidance #282 VI.A.5, VI.B.7 |
| Voluntary | Taking part is voluntary and owners can withdraw at any time | University of Missouri; Guidance #282 VI.C.1 |
| Approval | Which committee approved the study | Virginia Tech |
| Contact | One address, and whether a vet must refer | Virginia Tech; Guidance #282 VI.I |
| What to leave out | Safe, effective, FDA-endorsed, any promise of benefit | 21 CFR 511.1(b)(8)(iv); Guidance #282 V.B |
The consent form carries much more than this; see Informed consent for client-owned animal studies.
What stays the sponsor's and the investigator's job
Each of these is a person's job, not a system's: the protocol, the ethics review, the words of the listing and of the consent, the notice to FDA where an unapproved drug is shipped, the reporting of adverse events, and keeping the listing true until enrollment closes. A registry publishes what you send it. A data system holds what happens after an owner says yes.
Signalment is that data system. Once an owner answers your listing, they sign a versioned consent and keep the study diary on their own phone. The site's forms, randomization and audit trail sit in the same workspace. Signalment does not write, submit or host a registry listing, and it does not review your consent text. The page for practices shows how a study runs once owners have enrolled.
Sources
- 21 CFR 511.1, new animal drugs for investigational use: https://www.ecfr.gov/current/title-21/section-511.1
- FDA Guidance #85, VICH GL9, Good Clinical Practice: https://www.fda.gov/media/70333/download
- FDA Guidance #282 (draft), Informed Consent Forms for Studies that Enroll Client-Owned Companion Animals: https://www.fda.gov/media/172056/download
- Washington State University Libraries, Veterinary Medicine guide, consumer links: https://libguides.libraries.wsu.edu/veterinarymedicine/veterinaryconsumerlinks
- Tufts University, Webster Veterinary Library, AVMA Veterinary Clinical Trials Registry: https://vetlibrary.tufts.edu/find/databases-and-indexes/avma-veterinary-clinical-trials-registry
- Virginia Tech, Veterinary Clinical Research Office, clinical trials: https://research.vetmed.vt.edu/clinical-trials.html
- Cornell University College of Veterinary Medicine, clinical trials for veterinarians: https://www.vet.cornell.edu/hospitals/clinical-trials/veterinarians
- University of Missouri Veterinary Health Center, clinical trials: https://vhc.missouri.edu/clinical-trials/